Symptomatic benign prostatic hyperplasia (BPH)
Also known as: Symptomatic Benign Prostatic Hyperplasia
Drug | Drug Name | Drug Description |
---|---|---|
DB01126 | Dutasteride | An antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) in adult males by inhibiting 5-alpha reductase. |
DB01216 | Finasteride | An antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) and male pattern hair loss in adult males by inhibiting Type II 5-alpha reductase. |
Drug | Drug Name | Phase | Status | Count |
---|